EBUS-TBNA Diagnostic Yield and Complication in Patients Mediastinal Lymphadenopathy; Clinicorardiological and Pathological/microbiological Correlatio
Not Applicable
- Conditions
- Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere
- Registration Number
- CTRI/2023/04/051816
- Lead Sponsor
- Department of Pulmonary Medicine, SCB-MCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Mediastinal Lymphadenopathy
Exclusion Criteria
Patient <18 years of age
Bleeding diathesis
Patient with refractory hypoxia
Hemodynamically unstable patient
Chronic renal disease
HIV, HCV, HBsAg positive patients
Active smear positive tuberculosis patient
COVID-19 positive patients
Nonconsenting patient
History of recent acute coronary syndrome
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estimation of diagnostic yield and complication rate of EBUS-TBNA. <br/ ><br> <br/ ><br>Timepoint: 24 weeks <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Estimation of diagnostic yield and complication rate of EBUS-TBNA.Timepoint: 24 weeks